Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boon Cher Goh

Showing results (91-100 of 242) with videos related to

Pageof 25
Sort By:
Pharmacological Research|May 15, 2018
Potential role of genipin in cancer therapyMuthu K Shanmugam, Hongyuan Shen, Feng Ru Tang, et al.
Molecular Cancer|May 21, 2026
The Treg-cell death axis in lung cancer: implications for immune evasion and novel therapeutic strategiesWenping Fan, Qi An, Xiaoya Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Lack of association of single-nucleotide polymorphisms in pregnane X receptor, hepatic nuclear factor 4alpha, and constitutive androstane receptor with docetaxel pharmacokineticsLai-San Tham, Nicholas H G Holford, Sok-Ying Hor, et al.
Investigational New Drugs|August 26, 2009
Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanesDaniel Chan, Wee-Lee Yeo, Maricel Tiemsim Cordero, et al.
Targeted Oncology|June 4, 2025
A Phase I Study of the Anti-CEACAM6 Antibody Tinurilimab (BAY 1834942) in Patients with Advanced Solid TumorsLillian L Siu, David S Hong, Wolf-Dietrich Döcke, et al.
Pharmacological Research|September 16, 2024
Extracellular vesicles in the HCC microenvironment: Implications for therapy and biomarkersLe Cheng, Limin Zhang, Xiaoxiao Wang, et al.
International Journal of Cancer|February 26, 2021
Low-dose pembrolizumab in the treatment of advanced non-small cell lung cancerJia Li Low, Yiqing Huang, Kenneth Sooi, et al.
Cancer Letters|August 14, 2024
Extracellular vesicle-derived biomarkers in prostate cancer care: Opportunities and challengesXiaoxiao Wang, Limin Zhang, Le Cheng, et al.
Cancer Letters|September 11, 2021
Celastrol in cancer therapy: Recent developments, challenges and prospectsHannah Ying Lim, Pei Shi Ong, Lingzhi Wang, et al.
Scientific Reports|December 14, 2017
Non-malignant epithelial cells preferentially proliferate from nasopharyngeal carcinoma biopsy cultured under conditionally reprogrammed conditionsFenggang Yu, Yanan Lu, Lin Tao, et al.
Pageof 25

Showing results (91-100 of 242) with videos related to

Sort By:
Pageof 25
Pharmacological Research|May 15, 2018
Potential role of genipin in cancer therapyMuthu K Shanmugam, Hongyuan Shen, Feng Ru Tang, et al.
Molecular Cancer|May 21, 2026
The Treg-cell death axis in lung cancer: implications for immune evasion and novel therapeutic strategiesWenping Fan, Qi An, Xiaoya Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Lack of association of single-nucleotide polymorphisms in pregnane X receptor, hepatic nuclear factor 4alpha, and constitutive androstane receptor with docetaxel pharmacokineticsLai-San Tham, Nicholas H G Holford, Sok-Ying Hor, et al.
Investigational New Drugs|August 26, 2009
Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanesDaniel Chan, Wee-Lee Yeo, Maricel Tiemsim Cordero, et al.
Targeted Oncology|June 4, 2025
A Phase I Study of the Anti-CEACAM6 Antibody Tinurilimab (BAY 1834942) in Patients with Advanced Solid TumorsLillian L Siu, David S Hong, Wolf-Dietrich Döcke, et al.
Pharmacological Research|September 16, 2024
Extracellular vesicles in the HCC microenvironment: Implications for therapy and biomarkersLe Cheng, Limin Zhang, Xiaoxiao Wang, et al.
International Journal of Cancer|February 26, 2021
Low-dose pembrolizumab in the treatment of advanced non-small cell lung cancerJia Li Low, Yiqing Huang, Kenneth Sooi, et al.
Cancer Letters|August 14, 2024
Extracellular vesicle-derived biomarkers in prostate cancer care: Opportunities and challengesXiaoxiao Wang, Limin Zhang, Le Cheng, et al.
Cancer Letters|September 11, 2021
Celastrol in cancer therapy: Recent developments, challenges and prospectsHannah Ying Lim, Pei Shi Ong, Lingzhi Wang, et al.
Scientific Reports|December 14, 2017
Non-malignant epithelial cells preferentially proliferate from nasopharyngeal carcinoma biopsy cultured under conditionally reprogrammed conditionsFenggang Yu, Yanan Lu, Lin Tao, et al.
Pageof 25